*Together with

?The Future of Green Energy Storage ?

Good day, 360 –

Here are our top investing ideas today – these setups look primed! Be the best prepared trader on the Street!

HTCR – Up over 100% in pre-market after announcing new consulting agreement for upcoming IPO

LUCY – 2nd day play, closed up over 200% yesterday after filing patent for ChatGPT enabled eyewear

NUTX – Up over 20% after receiving $100 million in funding from Yorkville Advisors Global L.P.

*A Message on Behalf of Energy Sector Report

? Hot Stock of the Day ?

Elon Musk says a battery shortage is holding back Tesla.

It’s a MAJOR problem that every manufacturer is facing right now.

However, there is a small $3 stock right now that is meeting this challenge head-on.

This company is at the forefront of developing cleaner and more efficient lithium-ion batteries and has its focus on next-generation non flammable solid-state batteries.

Company insiders are such strong believers that they still own a whopping 62% of the shares.

Wall Street is warming up to the story as well. SeekingAlpha reports that analysts have an average price target that is over 204% higher than current levels.

Click here to learn more about the incredible opportunity while it is still at this level, and see if this stock deserves a place in your portfolio today!

*Sponsored by Lifewater Media. Please see disclosures below.

HTCR – Up over 100% in pre-market after announcing new consulting agreement for upcoming IPO

Heartcore Enterprises (HTCR) announced in afterhours that it had signed a consulting agreement with rYojbaba to assist the company in its efforts to go public and list on the Nasdaq.

HTCR is to receive $500,00 in initial fees as well as warrants to acquire 3% of rYojbaba stock.

In addition, HTCR announced that it had received $4.1 million of SYLA Technologies stock following its recent IPO. This is the company’s 10th Go IPO listing.

HTCR was up over 100% in pre-market on the announcement.

As of yesterday, HTCR’s market cap was $19.72 million according to Finviz with a Price Sales ratio of 2.24.

$1.72 has been support in the after-hours and pre-market and should be an important pivot level.

Above it there is potential resistance at $2.10, $2.20 and then the pre-market high at $2.35.

LUCY – 2nd day play, closed up over 200% yesterday after filing patent for ChatGPT enabled eyewear

Innovative Eyewear (LUCY) – developer and retailer of smart eyewear under the Lucyd(R), Nautica(R) and Eddie Bauer(R) brands – released a PR yesterday regarding it filing a patent for ChatGPT enabled eyewear.

“We believe we are the first smart eyewear company to provide (patent-pending), artificial intelligence voice accessibility on Bluetooth-enabled eyewear. With our new Lucyd app, we are continuing to make eyewear more flexible and smarter than ever before,” says Harrison Gross, CEO of Innovative Eyewear.

This news sent the stock up over 270% before closing around 200% higher on the day.

$3.85 was a resistance level yesterday, and acted as support in the after-hours and pre-market.

Above it, targets to the upside are $4.35, $4.50, $4.90, $5.15 and then yesterday’s higher of $5.50. Beyond that, $6 and then $7 comes into play.

Below $3.85, there is potential support at $3.50, $3.25, with $3. $2.80 and $2.30 below that.

Nutex Health (NUTX) announced in the after-hours that it had entered into a $100M pre-paid advance agreement with Yorkville Advisors Global L.P.

NUTX is a physician-led, technology-enabled integrated healthcare delivery system comprised of 20 state-of-the-art micro hospitals in 8 states and primary care-centric, risk-bearing physician networks.

“We intend to use proceeds of the funding to support the Company’s growth, accelerate its footprint, support opportunistic acquisitions, potential stock buybacks and for working capital,” stated Warren Hosseinion, M.D., President of Nutex Health.

The $1.15 area was resistance in the after-hours and has acted as support in the pre-market.

Targets to the upside are $1.25, $1.30 and then the pre-market high of $1.39.

Below $1.15 there is potential support at $1.10, $1 and then a gap to fill at $0.9562.

Economic Calendar (EST)

7:00am MBA Mortgage Applications

8:30am CPI

9:00am Fed Speaker Tom Barkin

10:00am Atlanta Fed Business Inflation Expectations

10:30am EIA Petroleum Report

2:00pm FOMC minutes

2:00pm Treasury Statement

Earnings for Today (After Market)


Top Headlines

TSP Leading Independent Auditor Greenlights TuSimple Autonomous Vehicle Testing and Safety Processes

TIGR UP Fintech unveils TigerGPT, the industry’s first AI investment assistant

LICY VinES and Li-Cycle Announce Strategic, Long-Term Battery Recycling Agreement

EVTV Envirotech Vehicles and Maddox Defense Inc. Enter into a Term Sheet for Proposed Business Combination

PSN Parsons’ Xator Awarded 3-Year $750M State Department Humanitarian Support Contract

KA: Kineta Announces First Patient Dosed in Phase 1/2 Clinical Study of KVA12123 for Advanced Solid Tumors

CNTG CENTOGENE Launches NEW CentoGenome(R), World’s Most Comprehensive Whole Genome Sequencing Solution for Diagnosis of Rare and Neurodegenerative Diseases

FSR: Optimized Engineering Leads All-electric Fisker Ocean Extreme SUV to Another European Market-leading Combined WLTP Range

OXUS: Oxus Capital, the promoters of the first Central Asian SPAC, to launch new $200 million Visionary Fund to drive impact investment globally

META Mass Layoffs And Absentee Bosses Create A Morale Crisis At Meta NYT

INTC China’s Vice President Han Zheng Told Intel CEO To Take Root In China, Help Maintain Stability Of The Global Industrial Supply Chain

ONCY: Oncolytics Biotech(R) Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders

PRMW: Primo Water Publishes Investor Presentation Detailing Company’s Transformation and Improvement Under Leadership of the Primo Water Board and Management Team

TRTN Triton International to be Acquired by Brookfield Infrastructure in a $13.3 Billion Take-Private Transaction

GRNA GreenLight Biosciences Releases Inaugural Sustainability Report

TESS: TESSCO Enters Into Definitive Merger Agreement

AVIR Atea Announces Presentation of Bemnifosbuvir Data Demonstrating Reduced Hospitalizations for COVID-19 Patients at 2023 European Congress of Clinical Microbiology & Infectious Diseases

RNLX: Data Supportive of KidneyIntelX Utility in Minorities and Veterans to Be Presented at the National Kidney Foundation Spring Clinical Meeting

LPTX Leap Therapeutics Announces Completion of Enrollment in Part A of the DeFianCe Study of DKN-01 for the Treatment of Colorectal Cancer Patients

AGLE: Aeglea BioTherapeutics Announces Interim Results from Ongoing Phase 1/2 Clinical Trial of Pegtarviliase for the Treatment of Classical Homocystinuria and Begins Process to Explore Strategic Alternatives

EPIX ESSA Pharma Announces Clinical Trial Support Agreement with Janssen to Evaluate EPI-7386 Combinations in Patients with Prostate Cancer

LUCY Innovative Eyewear, Inc. Files Patent For ChatGPT Enabled Smart Eyewear

MIRM Mirum Pharmaceuticals Announces Proposed Convertible Senior Notes Offering

AMYT: Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc

VRCA: Verrica Pharmaceuticals Announces Dosing of the First Patient in Part 2 of Phase 2 Study Evaluating VP-315 for the Treatment of Basal Cell Carcinoma

COP: ConocoPhillips Analyst & Investor Meeting Outlines Durable, Returns-Focused Value Proposition with Compelling Plan

ACB Aurora and MedReleaf Australia Launch IndiMed Tempo 26, Further Strengthening Product Offerings for Medical Cannabis Patients

TWTR Musk says Twitter is roughly breaking even, has 1,500 employees – Reuters

STBX Starbox Successfully Uses Cutting-Edge AR Technology to Enhance Its Cash Rebates System

CGTX: Cognition Therapeutics Announces New Scientific Publication on Therapeutic Potential of Targeting Sigma-2 Receptor for Age-related Degenerative Diseases

ADPT: Adaptive Biotechnologies Announces Translational Collaboration with Takeda to Measure Minimal Residual Disease with Its clonoSEQ(R) Assay Across Its Hematologic Malignancy Pipeline

KRP Kimbell Royalty Partners, LP Announces $143.1 Million Midland Basin Mineral and Royalty Acquisition

To Your Success!

Questions or concerns about our products? Email [email protected] (C) Copyright 2022, RagingBull – Refund Policy – Privacy Policy – Terms & Conditions

*PAID ADVERTISEMENT. RagingBull has been paid fourteen thousand dollars by ach bank transfer by Lifewater Media for advertising Dragonfly Energy from a period beginning on April 12, 2023 through April 13 of the same year. As a result of this advertisement and other marketing efforts, Raging Bull may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of this advertisement, the owners of Raging Bull, do not hold a position in Dragonfly Energy. This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of Dragonfly Energy, increased trading volume, and possibly an increased share price of the Dragonfly Energy securities, which may or may not be temporary and decrease once the marketing arrangement has ended.

FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. This advertisement is for educational and informational purposes only. All material information contained in this advertisement is based on information generally available to the public, which public information is believed to be reliable and accurate. Nevertheless, Raging Bull can guarantee the accuracy or completeness of the information. This advertisement does not purport to be a complete analysis of any company’s financial position. This advertisement or any statements made in it is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. The statements made in this advertisement should NOT be relied upon for purposes of investing in the companies mentioned in this advertisement, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security mentioned in this advertisement or in any other security or strategy. It is strongly recommended that you consult a licensed or registered professional before making any investment decision.

SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in any securities of the companies mentioned in this advertisement should do so with caution. Investing or transacting in any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions, and should use information from this advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments.

NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Raging Bull, or any of their owners, employees or independent contractors is currently registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization.

USE OF FORWARD-LOOKING STATEMENTS. Certain statements made in this advertisement may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Raging Bull does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the companies profiled in the Advertisements at https:// www. sec. gov/ edgar/searchedgar/companysearch.

WE MAY HOLD SECURITIES DISCUSSED. Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.

TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the advertisement is made or implied.



Leave your comment

Skip to content